Manufacturing: Page 11
-
Permission granted by Gilead Sciences
Trump administration: States to decide which hospitals get Gilead's COVID-19 drug
HHS will distribute to states some of the roughly 600,000 vials of remdesivir Gilead is donating to the U.S., but said decisions on which hospitals receive the drug will be made by state health agencies.
By Ned Pagliarulo • May 11, 2020 -
Moderna plans earlier start to late-stage test of coronavirus vaccine
A Phase 3 trial of Moderna's experimental vaccine could begin in early summer, several months sooner than what was already an ambitious target for starting this fall.
By Ned Pagliarulo • May 7, 2020 -
Permission granted by BioNTech SE
Pfizer, BioNTech launch U.S. trial of coronavirus vaccine
Initial vaccine data are expected within weeks as biotech and pharma companies intensify their search for a way to prevent the spread of COVID-19.
By Jonathan Gardner • May 5, 2020 -
Moderna, with government cash, taps Lonza to make 1 billion doses of COVID-19 vaccine
The deal gives Moderna more manufacturing might to make sufficient supplies of its experimental coronavirus vaccine, which it's advancing quickly.
By Ben Fidler • May 1, 2020 -
J&J contracts with Catalent to boost coronavirus vaccine production
The partnership is the second J&J has inked in recent weeks as it prepares sufficient capacity to supply 1 billion doses of its experimental vaccine.
By Kristin Jensen • April 30, 2020 -
Master Sgt. Hecht, Matt. (2020). [Photograph]. Retrieved from Flickr.
3M cites supply chain shift for getting grip on pandemic demand
Demand for N95 masks and healthcare equipment is on the rise, while other products are less needed, forcing the manufacturing giant to pivot quickly.
By Matt Leonard • April 28, 2020 -
Permission granted by Merck KGaA
Merck KGaA to spend $110M on new gene therapy facility in California
The investment continues a spate of build-outs by Merck KGaA, which, like its contracting peers, sees an opportunity in the fast-growing gene therapy field.
By Kristin Jensen • April 23, 2020 -
Thermo Fisher, Roche boosted by COVID-19 diagnostics, but warn of routine testing declines
Both companies disclosed big first quarter hits to business in China, and said impacts in the U.S. and Europe could be more apparent as the year goes on.
By Nick Paul Taylor • April 22, 2020 -
Master Sgt. Hecht, Matt. (2020). [Photograph]. Retrieved from Flickr.
Manufacturers call on government to help with production pivots to PPE
NAM, a top trade group, is lobbying for the federal government to provide more incentives for businesses that switch to producing essential goods like PPE.
By Matt Leonard • April 22, 2020 -
US government to back Moderna's coronavirus vaccine with up to $483M
The BARDA grant will allow Moderna to hire 150 more staff and accelerate testing of its vaccine, which entered a Phase 1 study in March and could soon move to a mid-stage trial.
By Ned Pagliarulo • Updated April 17, 2020 -
Fujifilm ramps up production of flu drug Avigan for COVID-19
Use of the drug, which isn't approved in the U.S., is controversial without fuller data showing evidence it works in treating the disease.
By Kristin Jensen • April 16, 2020 -
Philips launches scaled-down ventilator, inks production deals to boost output
The medtech has allied with smaller players Flex and Jabil, aiming to produce 4,000 units per week by the third quarter.
By Nick Paul Taylor • April 15, 2020 -
Permission granted by Gilead Sciences
Gilead working to quickly boost production of experimental coronavirus drug
CEO Daniel O'Day said Gilead would provide at no charge its current supply of remdesivir, enough to treat some 140,000 patients with severe COVID-19.
By Ned Pagliarulo • April 6, 2020 -
"200323-Z-IB607-0016" by New Jersey National Guard is licensed under CC BY-ND 2.0
DOJ allows medical suppliers to collaborate on manufacturing and distribution
Five major medial suppliers wrote to the agency seeking a reprieve from antitrust enforcement in the context of the COVID-19 pandemic.
By Emma Cosgrove • April 6, 2020 -
Emergent to produce Novavax's flu vaccine under CDMO deal
Recent late-stage results showed Novavax's candidate the equal of Sanofi's Fluzone, setting the stage for the Maryland drugmaker to file for FDA approval.
By Kristin Jensen • April 2, 2020 -
National Institute of Allergy and Infectious Disease. (2020). "Novel Coronavirus SARS-CoV-2" [Image]. Retrieved from Flickr.
J&J picks top coronavirus vaccine candidate; human tests to start in September
Together with BARDA, the pharma has agreed to spend $1 billion co-funding vaccine research, development and testing.
By Jacob Bell • March 30, 2020 -
China halts import of Bristol Myers cancer drug after inspection at US plant
Chinese drugmaker Beigene, which sells Bristol Myers' Abraxane in China, said it's bracing for a disruption in supply of the chemotherapy.
By Kristin Jensen • March 25, 2020 -
Drugmakers boost production of malaria pill touted by Trump as coronavirus treatment
Chloroquine, a decades-old generic therapy, has drawn attention as a potential therapy for COVID-19, although the evidence supporting its promise is thin.
By Ned Pagliarulo • Updated March 20, 2020 -
US automakers study medical manufacturing as coronavirus squeezes capacity
Switching to produce medical equipment will require new supply lines running to manufacturing facilities that are capable of delivering needed components.
By Matt Leonard • March 19, 2020 -
Courtesy of Centers for Disease Control and Prevention
How an 'overwhelmed' Buffalo lab facing coronavirus supply shortage signals nationwide struggles
Labs like the one in western New York face insufficient stocks of swabs and reagents as they attempt to gauge the outbreak's spread.
By Greg Slabodkin • March 18, 2020 -
Regeneron expects its antibody cocktail for coronavirus to enter human testing in early summer
The biotech is prepping manufacturing facilities so that, once the top antibody contenders are selected, clinical production can quickly begin. By the end of the summer, the aim is to make hundreds of thousands of doses per month.
By Jacob Bell • March 17, 2020 -
National Institute of Allergy and Infectious Diseases. (2020). "Novel coronavirus SARS-CoV-2" [Microscope image]. Retrieved from https://www.flickr.com/photos/nihgov/49565158908/in/album-72157713108522106/.
Vir, signaling its commitment, taps Biogen to make coronavirus treatment
For smaller biotechs like Vir, manufacturing is a likely roadblock to advancing any promising drug candidate that might emerge from initial testing.
By Kristin Jensen • March 12, 2020 -
Yujin Kim / MedTech Dive, original photo courtesy of U.S. Food and Drug Administration
Coronavirus spread prompts FDA to postpone nearly all overseas inspections
The agency's decision was based on U.S. government travel restrictions, but it said "alternative tools and methods" will help it maintain oversight.
By Jonathan Gardner • March 10, 2020 -
Hospitals dipping into emergency stocks to combat coronavirus
Community spread of COVID-19 has hospitals bracing for a rush of patients and payers waiving fees for telemedicine consults and extra drug supplies.
By Shannon Muchmore • March 10, 2020 -
After waffling, Qiagen agrees to $11.5B buyout by Thermo Fisher
The instruments maker will pay a 23% premium to take out Qiagen, adding to the diagnostics side of its business after investments in its contract drug offerings.
By Maria Rachal • March 3, 2020
Previous
